European glucose monitoring market set to double by 2016
This article was originally published in Clinica
Executive Summary
Europe’s continuous glucose monitoring (CGM) market will more than double by 2016, analysts Frost & Sullivan believe. This growth is in response primarily to the increasing demand for an easy-to-use and patient-friendly glucose-monitoring device. The segment will generate revenues totalling $52m in 2016, up from an estimated $23.5m in 2009, according to the report European Market for Continuous Glucose Monitoring, which covers the Benelux countries, France, Germany, Italy, Scandinavia, Spain and the United Kingdom.